Dolutegravir Confirmed as Effective Second-Line HIV Therapy Dolutegravir Confirmed as Effective Second-Line HIV Therapy

A new randomized trial bolsters efficacy evidence for dolutegravir and finds no benefit in switching from tenofovir in second-line HIV treatment.Medscape Medical News
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news